Cost-Effectiveness Analysis of the South African Infant National Immunization Program for the Prevention of Pneumococcal Disease

被引：0
|
作者：
Liping Huang
Cheryl L. McDade
Johnna E. Perdrizet
Michele R. Wilson
Sophie A. Warren
Susan Nzenze
Renilla Sewdas
机构：
[1] Pfizer Inc.,School of Public Health
[2] RTI Health Solutions,undefined
[3] University of the Witwatersrand,undefined
[4] ZAF,undefined
[5] Health and Value,undefined
[6] Pfizer Laboratories (Pty) Ltd,undefined
[7] ZAF,undefined
来源：
Infectious Diseases and Therapy | 2023年 / 12卷
关键词：
PCV; PCV13; PCV20; Pneumococcal disease; Vaccine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：933 / 950
页数：17
相关论文
共 50 条
  • [41] Cost-effectiveness of a pneumococcal conjugate immunisation program for infants in Switzerland
    Ess, SM
    Schaad, UB
    Gervaix, A
    Pinösch, S
    Szucs, TD
    VACCINE, 2003, 21 (23) : 3273 - 3281
  • [42] Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries
    S. M. A. A. Evers
    A. J. H. A. Ament
    G. L. Colombo
    H. B. Konradsen
    R. R. Reinert
    D. Sauerland
    K. Wittrup-Jensen
    C. Loiseau
    D. S. Fedson
    European Journal of Clinical Microbiology & Infectious Diseases, 2007, 26 : 531 - 540
  • [43] Cost-effectiveness analysis of implementing polygenic risk score in a workplace cardiovascular disease prevention program
    Mujwara, Deo
    Kintzle, Jen
    Di Domenico, Paolo
    Busby, George B.
    Botta, Giordano
    FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [44] Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries
    Evers, S. M. A. A.
    Ament, A. J. H. A.
    Colombo, G. L.
    Konradsen, H. B.
    Reinert, R. R.
    Sauerland, D.
    Wittrup-Jensen, K.
    Loiseau, C.
    Fedson, D. S.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2007, 26 (08) : 531 - 540
  • [45] Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany
    Alexander Kuhlmann
    J.-Matthias Graf von der Schulenburg
    The European Journal of Health Economics, 2017, 18 : 273 - 292
  • [46] Modeling the cost-effectiveness of infant vaccination with pneumococcal conjugate vaccines in Germany
    Kuhlmann, Alexander
    von der Schulenburg, J. -Matthias Graf
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2017, 18 (03): : 273 - 292
  • [47] COST-EFFECTIVENESS ANALYSIS OF AN EDUCATIONAL DRUG-ABUSE PREVENTION PROGRAM
    MITCHEL, ME
    HU, TW
    MCDONNELL, NS
    SWISHER, JD
    JOURNAL OF DRUG EDUCATION, 1984, 14 (03) : 271 - 292
  • [48] A cost-effectiveness analysis of a school-based obesity prevention program
    Wang, L
    Yin, Z
    Gutin, B
    Hanes, J
    Cavnar, M
    Moore, J
    Johnson, M
    Barbeau, P
    Thornburg, J
    OBESITY RESEARCH, 2004, 12 : A18 - A18
  • [49] COST-EFFECTIVENESS ANA LYSIS OF INCORPORATION OF THE HPV VACCINE TO THE NATIONAL IMMUNIZATION PROGRAM / NIP OF BRAZIL
    Novaes, H. M. D.
    Azevedo e Silva, G.
    Ayres, A.
    Itria, A.
    Rama, C.
    Sartori, A. M. C.
    De Soarez, P. C.
    Clark, A.
    Resch, S.
    VALUE IN HEALTH, 2013, 16 (07) : A685 - A685
  • [50] Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis
    Sinha, Anushua
    Levine, Orin
    Knoll, Maria D.
    Muhib, Farzona
    Lieu, Tracy A.
    LANCET, 2007, 369 (9559): : 389 - 396
12345